slides · global inventory
53 Jobs To Be Done
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 1,583
Current window 991-1,020
Pages 53
Rows per page 30
Loop
991-1,020 of 1,583
20
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
21
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
22
Clinical trial summary slide.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
23
The slide uses a process flow diagram to illustrate the randomized, double-blind, placebo-controlled study structure.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
24
The chart displays a time-course study of VAS (Visual Analog Scale) scores for 'feeling high' across three cohorts.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
23
The slide uses a logo-grid layout to demonstrate the breadth of university partnerships across six key subject areas.Coursera | Results Presentation Deck | 39 slides · Coursera
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
05
DraftKings | Results Presentation Deck | 11 slidesDraftKings | Results Presentation Deck | 11 slides · DraftKings
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
10
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
11
Includes scientific citation at the bottom.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide uses a 'Bench to Bedside' narrative structure to present scientific evidence.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
13
The slide uses a visual process flow to explain the mechanism of action.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide outlines a clinical trial structure with 5 cohorts ranging from 0.4 to 3.2 mg/kg.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
Includes clinical trial abbreviations and source citation in footer.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide appears to be a template or placeholder with only the title present.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The slide compares clinical trial data for two different drugs using different metrics (fold change vs median % reduction).Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide outlines a clinical trial protocol for Itolizumab in patients with active proliferative lupus nephritis (apLN).Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
22
Data includes age, gender, race, country, disease duration, treatment history, LN class, and renal function metrics.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
23
Data cut-off date: September 2, 2022.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
24
The slide uses a structured table-like layout to categorize safety findings.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
25
The chart shows concentration over time for different dosage groups (0.4 to 3.2 mg/kg) for Type A and Type B subjects.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
26
The chart uses stacked bars to visualize the breakdown of Complete Response (two categories), Partial Response, and No Response.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
27
The chart tracks subject progress over time (weeks) with markers for treatment milestones and clinical responses.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
28
The chart uses a waterfall-style visualization to show individual subject outcomes relative to a 50% reduction threshold.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
29
The chart includes error bars representing standard error (SE) and sample sizes (n) at each time point.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
30
The table compares interim analysis data for Itolizumab against historical AMP SoC data across 3, 6, and 12-month intervals.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The chart is a classic waterfall plot used in oncology clinical trials to demonstrate efficacy.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
09
Waterfall plot showing individual patient responses; includes specific clinical trial metrics (ORR, PFS, OS).TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit